\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
Aug. 2: Doctors in the region are seeing the “rebound” in COVID-19 cases in patients to what the White House reported Saturday that President Joe Biden is experiencing.
Biden tested negative for COVID from Tuesday to Friday last week, however on Saturday the White House said the president had tested positive via antigen tests. Biden continues to isolate himself in the White House Executive Residence with reports that he is experiencing a recurrence of symptoms.
The medical network is observing this “rebound” phenomenon in patients treated with Paxlovid, which is used to suppress COVID infection, said Dr. Roberto Colon, medical director of Miami Valley Hospital.
“We’ve noticed that there are more people reporting this rebound after you ‘finished taking Paxlovid,'” Colon said. He explained that a case of COVID rebound occurs when a patient contracts COVID, recovers, and then within a few days has a resurgence of the virus or an acute infection.
According to the FDA, Paxlovid has emergency use authorization for the treatment of mild to moderate COVID-19 in adults, as well as in certain pediatric patients over the age of 12, who are at the highest risk of progression to severe COVID-19. Clinical trial reading Paxlovid, the drug reduced the proportion of other people hospitalized or dying of COVID by 88%.
Colon said Paxlovid still works as advertised and prevents more serious ailments due to the virus, even when those rebound cases occur. The challenge with the COVID rebound is that other people are still contagious.
“We still don’t have a clear idea of how rebound phenomena occur,” Colon said, explaining that there hasn’t been a large enough study to answer this question and that rebound cases aren’t tracked. The president’s doctor said it was a “small percentage of patients” treated with Paxlovid.
These cases of rebound are other reinfections. Doctors describe reinfections as when COVID-19 patients get rid of the virus completely before re-contracting COVID-19 after a longer period of time, more than a few days.
Colon said doctors see this more with the new COVID-19 VARIANTS, such as the BA. 4 and BA. 5 subvariants of the Omicron variant. He explained that those new variants are different enough to trump immune defenses and make patients contract COVID again.
Doctors also hope that more reinfections will not be unusual over time in the pandemic.
“We see this often,” Colon said of COVID reinfections. He said the framework still provides some coverage of previous COVID antibodies.
The risk of COVID reinfection appears to be an increased risk of other people contracting prolonged COVID. Colon said that each infection a user receives increases the risk of more illnesses arising and increases the risk of prolonged COVID.
The Centers for Disease Control (CDC) describes prolonged COVID, or “post-COVID conditions,” as when other people who have become inflamed with the virus continue to feel the long-term effects of their infection. These can come with a variety of ongoing fitness issues, from general symptoms of fatigue to respiratory and cardiac symptoms, neurological symptoms such as “brain fog,” and digestive symptoms.
According to the CDC, a survey conducted in June showed that among adults in the U. S. In the U. S. who reported having covid-19 in the past, one in five adults also reported still having symptoms of prolonged COVID.
Studies are underway to make fitness officials better perceive COVID reinfections and the dangers associated with reinfection.